Effect of the calcium channel blocker in the balance of LPS-induced inflammatory cytokines expression and its protection of the liver

LI Gang,QI Xiao-ping,XU Zhe,CHEN Che,YANG Xiao-dong,WU Xiao-yu,SUN Zheng,LI Jie-shou
DOI: https://doi.org/10.3969/j.issn.1007-810X.2005.06.002
2005-01-01
Abstract:Objectives:To evaluate the effect of calcium channel blocker(verapamil) on pro-inflammatory and/or anti-inflammatory cytokines in liver and systemic circulation.Methods:24 Sprague-Dawley rats were divided into 3 group randomly: control(A),LPS(B) and Verapamil(C).LPS(10 mg/kg) was given intraperitoneally in B group.After 30 minutes of intraperitoneal administration of Verapamil(10 mg/kg body weight),the Sprague-Dawley rats were given an intraperitoneal injection of 10 mg/kg of LPS in C group.Sixty minutes after LPS exposure,the hepatic tissue and serum were collected and assayed for the level of pro-inflammatory cytokines(TNF-α and IL-6) and anti-inflammatory cytokine(IL-10) with ELISA.Results:Compared with control group,the hepatic and circulating level of TNF-α and IL-6 increased significantly(P<0.01) after LPS injection with the augment of serum ALT and TBIL(P<(0.01).) The increases of TNF-α and IL-6 levels in tissue and circulation were depressed greatly by verapamil(P<0.01) with the concentration of IL-10 being enhanced significantly(P<0.01)both in circulation and in situ and the decrease of serum ALT,TBIL and albumin levels(P<0.01). Conclusions:Calcium channel blocker(verapamil) may limit the early hepatic injury caused by LPS accompanied with the balance of pro-and anti-inflammatory cytokines in liver.
What problem does this paper attempt to address?